The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
Abstract
PURPOSE: In view of the increasing number of patients treated with breast-conserving treatment (BCT) for ductal carcinoma-in-situ (DCIS), risk factors for recurrence and metastasis should be identified. PATIENTS AND METHODS: Clinical and pathologic characteristics from patients with DCIS in the European Organization for Research and Treatment of Cancer trial 10853 (excision with or without radiotherapy) were related to the risk of recurrence. Pathologic features were derived from a central review of 863 of the 1,010 randomized cases (85%). The median follow-up was 5.4 years. RESULTS: Factors associated with an increased risk of local recurrence in the multivariate analysis were young age (≤ 40 years) (hazard ratio, 2.14; P = .02), symptomatic detection of DCIS (hazard ratio, 1.80; P = .008), growth pattern (solid and cribriform) (hazard ratios, 2.67 and 2.69, respectively; P = .012), involved margins (hazard ratio, 2.07; P = .0008), and treatment by local excision alone (hazard ratio, 1.74; P = .009). The risk of invasive recurrence was not related to the histologic type of DCIS (P = .63), but the risk of distant metastasis was significantly higher in poorly differentiated DCIS compared with well-differentiated DCIS (hazard ratio, 6.57; P = .01). CONCLUSION: Patients with poorly differentiated DCIS have a high risk of distant metastasis after invasive local recurrence. Margin status is the most important factor in the success of BCT for DCIS; additionally, young age and symptomatic detection of DCIS have negative prognostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Fisher, B., Dignam, J., Wolmark, N., Mamounas, E., Costantino, J., Poller, W., Fisher, E. R., Wickerham, D. L., Deutsch, M., Margolese, R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.441 · Cited by 894
Fisher, B., Costantino, J., Redmond, C., Fisher, E., Margolese, R., Dimitrov, N., Wolmark, N., Wickerham, D. L., Deutsch, M., Ore, L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282201 · Cited by 827
Prognostic classification of breast ductal carcinoma-in-situ
Poller, D. N., Barth, A., Slamon, D. J., Silverstein, M. J., Gierson, E. D., Coburn, W. J., Waisman, J. R., Gamagami, P., & Lewinsky, B. S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90982-6 · Cited by 679
The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
Silverstein, M. J., Lagios, M. D., Groshen, S., Waisman, J. R., Lewinsky, B. S., Martino, S., Gamagami, P., & Colburn, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401902 · Cited by 673
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S., Abner, A., Recht, A., Vicini, F., & Harris, J. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.888 · Cited by 579
Julien, J.-P., Bijker, N., Fentiman, I. S., Peterse, J. L., Delledonne, V., Rouanet, P., Avril, A., Sylvester, R., Mignolet, F., Bartelink, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06341-2 · Cited by 514
Self-citationAge as prognostic factor in premenopausal breast carcinoma
de la Rochefordière, A., Campana, F., Fenton, J., Vilcoq, J. R., Fourquet, A., Asselain, B., Scholl, S. M., Pouillart, P., Durand, J.-C., & Magdelenat, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92407-k · Cited by 480
Schnitt, S. J., Connolly, J. L., Tavassoli, F. A., Fechner, R. E., Kempson, R. L., Gelman, R., & Page, D. L. (1992) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199212000-00001 · Cited by 409
Long-term follow-up of in situ carcinoma of the breast.
Eusebi, V., Feudale, E. A. A., Foschini, M. P., Micheli, A., Conti, A., Riva, C., Palma, S. D., & Rilke, F. O. (1994) · PubMed · Cited by 294
Duct Carcinoma in Situ: Pathology and Treatment
Lagios, M. D. (1990) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)45185-6 · Cited by 290
Risk factors in breast-conservation therapy.
Borger, J., Kemperman, H., Hart, A., Peterse, H., van Dongen, J., & Bartelink, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.653 · Cited by 262
Elkhuizen M.D., P. H. M., van de Vijver M.D., P. D., Hermans Ph.D., J., Zonderland M.D., H. M., van de Velde M.D., P. D., & Leer M.D., P. D. (1998) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/s0360-3016(97)00917-6 · Cited by 237
Cited by
Ductal Carcinoma in Situ of the Breast
Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., & Kaelin, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031301 · Cited by 759
Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2010) · JNCI Monographs · doi:10.1093/jncimonographs/lgq039 · Cited by 672
Bijker, N., Meijnen, P., Peterse, J. L., Bogaerts, J., Van Hoorebeeck, I., Julien, J.-P., Gennaro, M., Rouanet, P., Avril, A., Fentiman, I. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1366 · Cited by 663
Self-citationBreast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Narod, S. A., Iqbal, J., Giannakeas, V., Sopik, V., & Sun, P. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2510 · Cited by 613
Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
Virnig, B. A., Tuttle, T. M., Shamliyan, T., & Kane, R. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp482 · Cited by 608
Metadata
- Authors
- Bijker, N., Peterse, J. L., Duchateau, L., Julien, J.-P., Fentiman, I. S., Duval, C., Di Palma, S., Simony-Lafontaine, J., de Mascarel, I., & van de Vijver, M. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-04-15
- Volume
- 19
- Issue
- 8
- Pages
- 2263-2271
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2179335453
- Cited by
- 496
- References
- 15
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.